相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。
Article
Health Care Sciences & Services
Yoseph Solomon et al.
Summary: This study assessed the immediate symptoms associated with taking the Oxford-AstraZeneca COVID-19 vaccine. The results showed that most healthcare providers developed injection site symptoms like pain and tenderness after vaccination. Mild symptoms were common, while severe symptoms were rare.
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE
(2021)
Review
Microbiology
Shan Su et al.
Summary: In the development of a COVID-19 vaccine, it is crucial to prioritize safety and efficacy evaluations, drawing lessons from past vaccine development efforts. Su, Du, and Jiang summarize the lessons from previous vaccine development for other viruses, highlighting how mechanisms of vaccine-associated disease enhancement can inform the development of a safe and effective COVID-19 vaccine.
NATURE REVIEWS MICROBIOLOGY
(2021)
Article
Medicine, General & Internal
Merryn Voysey et al.
Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.
Article
Immunology
Malik Sallam et al.
Summary: The low acceptance rates of COVID-19 vaccines, especially in Jordan and Kuwait among other Arab countries, could hinder the control of the pandemic. This highlights the harmful impact of misinformation and conspiracy beliefs on vaccine hesitancy, emphasizing the importance of vigilant fact checking.
Review
Cell Biology
Shivaji Kashte et al.
Summary: The COVID-19 pandemic has posed unprecedented challenges globally, leading to rapid development and distribution of vaccines to combat the virus. However, the accelerated development and Emergency Use Authorization of COVID-19 vaccines still raise many unanswered questions and challenges.
Article
Immunology
Miloslav Klugar et al.
Summary: A survey in Czech healthcare workers revealed that a high percentage were willing to accept COVID-19 vaccine booster doses, with medical professionals, males, and older participants more likely to accept them. Perceived effectiveness against severe illness, symptomatic infection, and community transmission was a significant predictor for acceptance, while safety and ethical considerations should be addressed when communicating with healthcare workers.
Article
Medicine, General & Internal
Alexis L. Beatty et al.
Summary: This study found that factors associated with greater odds of adverse effects after COVID-19 vaccination included receiving full vaccination dose, vaccine brand, younger age, female sex, and having a prior COVID-19 infection. Serious vaccine adverse effects were rare in this real-world cohort.
Article
Medicine, General & Internal
Abanoub Riad et al.
Summary: The study conducted a survey on the side effects of the Pfizer-BioNTech COVID-19 vaccine among healthcare workers in the Czech Republic, revealing common side effects such as injection site pain, fatigue, and headache. Younger age groups and individuals who received two doses of the vaccine were more likely to experience side effects, with the overall prevalence of side effects higher than reported by the manufacturer.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Immunology
Eyad Qunaibi et al.
Summary: This study evaluated COVID-19 vaccine hesitancy and perceived barriers among Arabic-speaking HCWs worldwide. Results showed significant hesitancy rates among HCWs in and outside Arab countries, with the highest rates in western Arab states. Common reasons for hesitancy included concerns about side effects and distrust in vaccine production and healthcare policies.
Article
Medicine, General & Internal
Bewunetu Zewude et al.
Summary: The study found that while most healthcare workers' expectations of the side effects of the COVID-19 vaccine align with the normal reactions of the vaccine, a significant proportion of participants reported that they perceive the COVID-19 vaccine to have life-threatening side effects. These fears have also played a role in affecting vaccine uptake.
PRAGMATIC AND OBSERVATIONAL RESEARCH
(2021)
Article
Biochemistry & Molecular Biology
Julio S. Solis Arce et al.
Summary: The acceptance of COVID-19 vaccines in LMICs is higher compared to the United States and Russia, with a focus on personal protection and concerns about side effects. Healthcare workers are the most trusted sources of guidance in LMICs for COVID-19 vaccines, suggesting that prioritizing vaccine distribution to these countries could help advance global immunization coverage.
Article
Multidisciplinary Sciences
Abiy Tadesse Angelo et al.
Summary: In this study, the intention of health care workers to accept the COVID-19 vaccine was found to be low. Professional types, history of chronic illness, perceived degree of risk of COVID-19 infection, attitude toward COVID-19, and preventive practices were identified as factors influencing the intention of health care workers to accept the COVID-19 vaccine.
Article
Biotechnology & Applied Microbiology
Dorcas Serwaa et al.
Summary: The study found that 80.7% of healthcare workers experienced adverse reactions after receiving the COVID-19 vaccine, lasting between 0 and 2 days. The most common adverse reactions were general body weakness, headache, and fever. Healthcare workers aged 35-39 and 40-44 had lower odds of adverse reactions compared with those aged 25-29.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2021)
Article
Environmental Sciences
Abanoub Riad et al.
Summary: This study aims to actively monitor the safety and effectiveness of COVID-19 vaccines globally in three phases, including short-term side effects, booster doses' side effects, and long-term safety and effectiveness. The protocol has been registered on ClinicalTrials.gov, with the identifier NCT04834869.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2021)
Article
Public, Environmental & Occupational Health
Yao Rodion Konu et al.
Summary: A study in Togo showed a high prevalence of severe adverse events (SAEs) among healthcare professionals after receiving the ChAdOx1 nCoV-19 vaccine, especially in young individuals and females. These findings are important for managing SAEs related to COVID-19 vaccines and suggest the possible use of pain relievers or fever reducers for young vaccine recipients.
ARCHIVES OF PUBLIC HEALTH
(2021)
Article
Health Care Sciences & Services
Yitayeh Belsti et al.
Summary: The study revealed that only 31.4% were willing to take the COVID-19 vaccine. Factors such as gender, age, marital status, residence, occupation, absence of health-related job, religion, and education level were statistically significantly associated with willingness to receive the COVID-19 vaccine.
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE
(2021)
Article
Public, Environmental & Occupational Health
Rajiv Chowdhury et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY
(2020)
Article
Infectious Diseases
Joel R. Koo et al.
LANCET INFECTIOUS DISEASES
(2020)
Article
Public, Environmental & Occupational Health
Helen Petousis-Harris
Editorial Material
Medicine, General & Internal
Francois Lamontagne et al.
BMJ-BRITISH MEDICAL JOURNAL
(2020)
Article
Health Care Sciences & Services
Erik von Elm et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY
(2008)
